The aim of the Juvenile Diabetes Cure Alliance is to see a Practical Cure for type 1 diabetes become widely available in the next 15 years.

  • JDCA COMMUNITY SIZE. MEMBERS, DONORS, VOLUNTEERS

    400,000

  • T1D FREE REPORTS PUBLISHED

    500+

  • # OF YEARS PUBLISHING THE DEFINITIVE STATE OF THE CURE FOR T1D

    11

  • MORE-FOR-A-T1D-CURE PETITION SIGNATURES

    376,000

Latest Research & Reports

On Tuesday of this week, JDRF released financial statements from its most recent fiscal year, FY2022 (which started July 1, 2021 and ended on June 30, 2022) and is particularly noteworthy because it is the first statement after the end of the COVID crisis.

Stem cell centers in Mexico and South America promise game-changing treatments for T1D. But is it safe? Effective? Worth the risk? This report takes a closer look.

Vertex gets a green light to start a T1D practical cure trial which combines stem-cell derived insulin producing beta cells with cell protection.

A Timeline of ADA's answer to a letter offering big-picture suggestions about how to do more for a T1D cure by hiring lawyers and legal aggression

A letter outlining recommendations about how the ADA can do more for a T1D cure.

An February 9 article in the Wall Street Journal ('WSJ') laid bare two different approaches in discussion:  appointed versus elected.  Although the Yale debate is ongoing, this topic is worth the attention of all non-profit executives, including those working in Diabetes.

Why we continue advocating for a T1D cure everyday...

  • Voices of the Cure Petition

    "I signed for my Granddaughter Addison. Our world is a brighter place with her in it. She is such a trooper with everything she has gone through and she knows so much about her disease. Praying for a cure, as this is such a horrible disease" -- Renee B.

Subscribe for the Latest T1D Practical Cure News & Analysis

* indicates required
Join the mailing list!
Join the mailing list!

When you join our email list, you'll be the first to hear all the latest T1D Practical Cure news.